Brief: Bioxytran Announces Positive Phase 2 Trial Results Were Featured In “Vaccines” A Peer-Reviewed Journal
29/03/2023 12:20
March 29 (Reuters) - Bioxytran Inc BIXT.PK :
* BIOXYTRAN ANNOUNCES POSITIVE PHASE 2 TRIAL RESULTS WERE
FEATURED
IN “VACCINES” A PEER-REVIEWED JOURNAL
Source text for Eikon: ID:nGNXbW2s44
Further company coverage: BIXT.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bioxytran
See all newsUS officials pressed China on rare earths, farm goods commitments, Bessent says (updated)
Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst (updated)
Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst
Brief: Bioxytran Inc Reports Positive Phase 1B/2A Clinical Study Results For Prolectin-M, Broad-Range Antiviral Drug In Mild To Moderate Covid-19
Brief: Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance With Prolectin-Mbioxytran